Dietary Phosphorus to Protein Ratio for the Mexican Population with Chronic Kidney Disease

Puchulu, María Bernardita; Ogonowski, Natalia; Sanchez-Meza, Fabiola; Espinosa-Cuevas, Ángeles; Miranda-Alatriste, Paola

doi:10.1080/07315724.2018.1501327

Cited by 2 publications

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…in México, obesity represents a highly prevalent disorder, which is a consequence of the eating disorder that affects them, which does not exempt kidney patients. This public health problem requires effective strategies to help reduce the prevalence of associated metabolic and hypertensive diseases [12,13]. Changes in lifestyle and diet transgression in the general population and in the population receiving dialysis, contribute decisively to increase the levels of phosphorus, sodium and potassium, which definitely expedite vascular damage and increase cardiovascular risk [14,15].…”

Section: International Journal Of Nephrology and Kidney Failurementioning

confidence: 99%

Hyperphosphatemia in Dialysis Patients National Multicenter Study

MD¹,

RS²,

ES³

et al. 2022

Int J Nephrol Kidney Fail

View full text Add to dashboard Cite

Introduction: Hyperphosphatemia (HPFT) is a complication that is exacerbated proportionally to the degree of kidney damage, and leads to vascular calcification and increased cardiovascular risk. The objective of the present study is to determine the frequency of hyperphosphatemia in patients with chronic dialysis treatment. Material and methods: This is a cross-sectional, observational, retrospective and analytical study. Real-life national multicenter study, conducted from January 1 to March 31, 2022. It includes subjects with chronic dialysis (>3 months stay), >16 years, from the public and private sectors. Does not include patients treated with phosphate binders or vitamin D receptor analogs; only treated with calcium derivatives in different formulations. Gender, age, causes of kidney failure, serum phosphorus values (mg/dL), calcium (mg/dL) and parathyroid hormone (pg/mL) are identified. Results: 2,176 subjects, 1,205 from the public sector (55%) and 971 private (45%). 1,063 (49%) male and 1,113 female (51%), with a mean age of 51.4 years (range 16-88). 794 with diabetes (36%), 559 arterial hypertension (26%) and 823 unknown (38%). The mean serum calcium values were 8.75 mg/dL (SD ± 1.01; range: 6.1-12.7) and phosphorus 5.15 mg/dL (SD ± 3.04; range: 2.5-18.1). 1,435 subjects presented HPFT (66%), 903 mild (41%), 450 moderate (21%, mean 5.7 mg/dL) and 82 severe (4%, mean: 9.2 mg/dL). Parathyroid hormone was determined in 33% (mean 614.87 pg/ mL, SD 628.64; range: 53.3 -3,803). Conclusions: HPFT is frequent in patients with chronic dialysis, it affects regardless of gender, age, primary cause of kidney disease and even after receiving adequate dialysis treatment. Significant increase in HPFT was observed in peritoneal dialysis patients.

show abstract

Section: International Journal Of Nephrology and Kidney Failurementioning

confidence: 99%

Hyperphosphatemia in Dialysis Patients National Multicenter Study

MD¹,

RS²,

ES³

et al. 2022

Int J Nephrol Kidney Fail

View full text Add to dashboard Cite

show abstract

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia

Palafox-Serdán¹,

Luna-Montiel²,

Pablo-Franco³

et al. 2020

Nutrients

View full text Add to dashboard Cite

Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country.

show abstract

Dietary Phosphorus to Protein Ratio for the Mexican Population with Chronic Kidney Disease

Cited by 2 publications

References 44 publications

Hyperphosphatemia in Dialysis Patients National Multicenter Study

Hyperphosphatemia in Dialysis Patients National Multicenter Study

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia

Contact Info

Product

Resources

About